All News

Pharmacy Technician Verification | 11/17/2020

Please note: 
A Pharmacy Technician's application status can be tracked via the Licensing Gateway by the employer. Log in to the Gateway and access the facility record and view the employee's status. 

Criminal Background Processing Change | 9/24/2020

For application purposes, you must request a standard FBI fingerprint card, form No. FD-258 used by the FBI for noncriminal fingerprinting from the Mississippi Board of Pharmacy. ​No other cards will be accepted. All completed cards must be mailed directly to:

Mississippi Department of Public Safety
Criminal Information Center
Applicant Processing
PO Box 958
Jackson, MS 39205-0958

UPDATED: Chloroquine and Hydroxychloroquine Information | 8/4/2020

It has come to our attention that there is some confusion over prescribing and dispensing chloroquine and hydroxychloroquine. The Board of Pharmacy did not restrict the usage of these medications. At the time of the previous guidance issued, there was a shortage, and many hospitals were using this medication as a key therapy.

As current efforts are underway to combat the COVID-19 pandemic, concern has been reported on the issuance of prescriptions and dispensing of hydroxychloroquine and chloroquine by pharmacies for prevention and treatment of COVID-19. The Board of Pharmacy has no purview over medications that a provider prescribes. Pharmacists should exercise caution dispensing these medications in a community setting.

At present, the FDA has not approved the use of chloroquine or hydroxychloroquine for COVID-19 prophylaxis or treatment. The prescribing physician should monitor a patient’s care.

Medication side effects, drug interactions, contraindications and laboratory monitoring requirements should also be considered when dispensing these medications for the treatment of COVID-19. There is a potential for toxicity. Meeting those monitoring needs for patients could be limited.

Pharmacists and prescribers must also consider that patients currently taking hydroxychloroquine for FDA approved indications could be affected by this prescribing. Pharmacists should monitor supplies of chloroquine and hydroxychloroquine for medication availability.

Providers prescribing hydroxychloroquine to patients for other indications (i.e., lupus, rheumatoid arthritis) are encouraged to note the indication on any new prescription issued.

Please note, pharmacists are encouraged to use their professional judgement and as always, are allowed to deny prescriptions based on this judgement as necessary.

This is a constantly evolving situation. As additional data is available, current information could be subject to change. Please continue to check your email from the Mississippi Board of Pharmacy and our website, www.mbp.ms.gov, for updated information pertaining to COVID-19.

 

Sincerely,

Jillian Foster

President

Mississippi Board of Pharmacy

Susan McCoy

Executive Director

Mississippi Board of Pharmacy

 ​

​​​

Amending or Creating a New Regulation | 8/3/2020

Curious about how regulations are amended or created? Check out this diagram!





News from the DEA | 7/21/2020

DEA has eliminated paper registration and renewal notifications and moving toward the ONLINE registration and renewal process.  Paper notifications will no longer be mailed.  Therefore, it is imperative that DEA has the correct email address of the registrant or their designated point of contact.  Registrants without email addresses will be contacted by DEA personnel in order to update the notification database.  Registrants may also directly contact Registration Support Specialists, Julie (571) 362-4890 or Connie (571) 362-4891) who handle the states of Louisiana, Arkansas, Alabama and Mississippi.  Additional information can be found on the DEA website: www.DEAdiversion.usdoj.gov, Registration Support.​

Mississippi Board of Pharmacy Swears in Board Members and Appoints Officers | 7/17/2020

The Mississippi Board of Pharmacy welcomed two new board members at the third quarter meeting held in Jackson on July 16. Ronnie Bagwell of Brandon and Tony Waits of Prentiss will each serve a five-year term as board members.“We, at the Board of Pharmacy, are excited about both Ronnie and Tony joining our Board. They bring many years of experience in the practice of pharmacy that will serve them and us well in the decisions that are required of the Board and staff. We look forward to the contributions that they will make,” Executive Director Susan McCoy.

Bagwell, a Brandon resident brings over 25 years of experience to the position. He is the owner of Marty’s Pharmacy and Compounding Center in Flowood and has been the Pharmacist-in-Charge of Hospice Ministries inpatient facility since 1998. Bagwell has served as the president of the Mississippi Pharmacists Association.

Waits is a resident of Prentiss and has been working in pharmacy for over 30 years. He is the owner of Hudson Drugs in Prentiss. He has served on the Board of Mississippi Independent Pharmacist Association, the Baptist Medical Dental Mission International and the Board of Trustees of Pearl River Community College throughout the years.

Additionally, the Mississippi Board of Pharmacy elected Jillian Foster of Olive Branch to the position of president. Appointed to the Board in 2016, Foster is currently the System Pharmacy Service Line Administrator for Baptist Memorial Healthcare Corporation (BMHCC), where she provides strategic directions to the BMHCC pharmacy teams across 14 hospitals and 19 infusion centers in Mississippi, Tennessee, and Arkansas.

The Board of Pharmacy named Larry Calvert Vice President, and Todd Barrett as Secretary for the 2020-2021 term. (Left to right: Tony Waits, District 4, Jillian Foster, District 1 and President, Ronnie Bagwell, Institutional at Large, Ryan Harper, District 3, Guy Phillips, Retail at Large, Todd Barrett, District 2 and Secretary, Larry Calvert, District 5 and Vice President.)


WIC + Pharmacies | 6/25/2020

The Mississippi WIC Program is looking for licensed pharmacies in the state of Mississippi to join our team. Pharmacies are asked to apply for the Mississippi WIC Program to provide specialized medical formula and nutritionals to WIC participants. Within the past month, you may have received a mailer from the MSDH WIC Program. The mailer contained a USB drive with additional information about the program.

To apply, please complete a vendor application located at www.freshnewwic.com. Pharmacies are required to submit the vendor application, Form W-9, proof of ownership (copy of lease, deed, bill of sale, etc.), pharmacy price survey, vendor technology survey, and a copy of the pharmacy license. The pharmacy price survey and vendor technology survey can also be found at www.freshnewwic.com.

Please view the attached flyer for more details. If you have any questions or concerns, please feel free to email the Mississippi WIC Vendor Management Team at vmu@msdh.ms.gov. 

WIC + Pharmacies Flyer​

2020 CE Requirements Update | 5/13/2020

Change to Mississippi CE Requirements for 2020 
During the Meeting of the Mississippi Board of Pharmacy on May 12, 2020, the Board unanimously agreed to suspend the LIVE Continuing Education Requirement for pharmacists in 2020. Pharmacists, upon request, will still be required to submit evidence of five (5) hours of opioid abuse and prevention/ drug of abuse/ addiction-related issues and a total of 15 hours for the year 2020.

The Script Volume 4 April 2020 | 4/8/2020




A new issue of The Script, the Mississippi Board of Pharmacy's quarterly newsletter, is out! Click Here to view the latest issue. We encourage you to make this available to your employees and would love to hear your feedback!​​
​​​

DEA Decision Tree | 4/1/2020

In response to the COVID-19 public health emergency declared by the Secretary of Health and Human Services, the Drug Enforcement Administration (DEA) has adopted policies to allow DEA-registered practitioners to prescribe controlled substances without having to interact in-person with their patients.  This chart only addresses prescribing controlled substances and does not address administering or direct dispensing of controlled substances, including by narcotic treatment programs (OTPs) or hospitals.  These policies are effective beginning March 31, 2020, and will remain in effect for the duration of the public health emergency, unless DEA specifies an earlier date.

This decision tree merely summarizes the policies for quick reference and does not provide a complete description of all requirements.  Full details are on DEA’s COVID-19 website (https://www.deadiversion.usdoj.gov/coronavirus.html​), and codified in relevant law and regulations.
Under federal law, all controlled substance prescriptions must be issued for a legitimate medical purpose by an individual practitioner acting in the usual course of his/her professional practice.  21 CFR 1306.04(a).  In all circumstances when prescribing a controlled substance, including those summarized below, the practitioner must use his/her sound judgment to determine that s/he has sufficient information to conclude that the issuance of the prescription is for a bona fide medical purpose.  Practitioners must also comply with applicable state law.

​​​

CII Resolution Modification | 3/30/2020

Modification to the Resolution Passed by the Board on March 18, 2020, Addressing Oral Prescriptions for Schedule II Controlled Substances

 

The resolution passed by the Mississippi Board of Pharmacy on March 18, 2020, addressing oral prescriptions for Schedule II controlled substances is modified by the following guidance put out by the DEA:

 This is a guidance letter clarifying the circumstances under which oral schedule II prescriptions are permitted and provides temporary exceptions due to the Public Health Emergency declared by the Secretary of Health and Human Services. 

 

The Controlled Substances Act, 21 U.S.C. 801 et seq., provides that a pharmacist may not dispense a schedule II controlled substance without a written prescription with the exception of an oral prescription in emergency situations.  According to 21 CFR 1603.11(d), to issue an emergency oral prescription, the quantity prescribed and dispensed is to be limited to the amount adequate for treatment of the patient during the emergency period; prescription shall be immediately reduced to writing by pharmacist and contain all information required in 1306.05, except for prescribing practitioner’s signature; if pharmacist does not know the individual prescribing practitioner, the pharmacist must make a reasonable effort to determine that the oral authorization came from a registered individual practitioner; and within 7 days after authorizing an emergency oral prescription, the individual prescribing practitioner shall cause a written prescription for the emergency quantity prescribed to be delivered to the dispensing pharmacist. 

 

In addition to the exception stated above, DEA announces two temporary exceptions: 

(1) practitioners have 15 days to deliver the follow-up paper prescription to the dispensing pharmacy; and  

(2) practitioners are allowed to send the follow-up prescription via facsimile, photograph, or scan to the pharmacy in place of the paper prescription. 

 

The practitioner must ensure that for whichever method they use, the prescription contains all required information stated in 1306.05 and 1306.11(d), including a statement that prescription is “Authorized for Emergency Dispensing.”  Practitioners who choose to send this specific type of prescription to the pharmacy via facsimile, photograph, or scan must maintain the original paper prescription in the patient file. 

​​​​

Hand Sanitizer Update | 3/23/2020

​​The Board unanimously voted to allow any permitted pharmacy that compounds hand sanitizer pursuant to the FDA Guidance issued March 2020, Policy for Temporary Compounding of Certain Alcohol-Based Hand Sanitizer Products During the Public Health Emergency, to sell such product to other pharmacies in-state for resale during the duration of the Governor’s Declaration of Emergency.​​​​​​​​​​

CLARIFICATION OF PRESCRIPTION SIGNATURE REQUIREMENTS | 3/20/2020

​​

CLARIFICATION OF PRESCRIPTION SIGNATURE REQUIREMENTS

The Mississippi Board of Pharmacy is charged with the protection of the public health as it relates to patient safety, patient health, patient access, and patient services. Governor Reeves declared a state of emergency on March 14, 2020, concerning the coronavirus and the potential spread of COVID-19. As a result of COVID-19 many patients are sheltering at home creating an increased need for home / residential delivery. All of us are concerned about personal/physical contact during this crisis.

The Board has received numerous questions concerning the shipment, mail or delivery of prescription drugs. In the past few days, some Pharmacy Benefit Managers (PBMs) have issued statements regarding the shipment, mailing or delivery of prescription medications as it relates to signatures.

Pharmacists must use their professional judgment in determining your specific procedures but must, at minimum, follow all state and federal laws and rules as it relates to this issue. Mississippi law may not supersede certain federal program requirements such as CMS, Mississippi Medicaid or laws such as ERISA.

CONTROLLED SCHEDULE II PRESCRIPTIONS-

Mississippi law (§ 41-29-125, 2.) reads in part

(2) Whenever a pharmacy ships, mails or delivers any Schedule II controlled substance listed in Section 41-29-115 to a private residence in this state, the pharmacy shall arrange with the entity that will actually deliver the controlled substance to a recipient in this state that the entity will: (a) deliver the controlled substance only to a person who is eighteen (18) years of age or older; and (b) obtain the signature of that person before delivering the controlled substance. The requirements of this subsection shall not apply to a pharmacy serving a nursing facility or to a pharmacy owned and/or operated by a hospital, nursing facility or clinic to which the general public does not have access to purchase pharmaceuticals on a retail basis.

All pharmacies must follow the requirements as stated above in the shipment, delivery or mailing of SCHEDULE II controlled substances.

NON-CONTROLLED PRESCRIPTIONS-

Mississippi law (§ 73-[21-183), known as the PHARMACY AUDIT INTEGRITY ACT, reads in part:

Section (1), (l)

Any prescription that complies with state law and rule requirements may be used to validate claims in connection with prescriptions, refills or changes in prescriptions; …(r) A recoupment shall not be based on:

(i) Documentation requirements in addition to or exceeding requirements for creating or maintaining documentation prescribed by the State Board of Pharmacy; or…

(ii) A requirement that a pharmacy or pharmacist perform a professional duty in addition to or exceeding professional duties prescribed by the State Board of Pharmacy;

MISSISSIPPI MEDICAID-

Rule 1.12: Beneficiary Signature

A. The pharmacy must obtain the signature of the beneficiary or his/her representative signature and their relationship to the beneficiary for each prescription received with the exception of beneficiaries living in long-term care facilities, i.e. nursing facilities, intermediate care facilities for individuals with intellectual disabilities (ICF/IID) facilities and/or psychiatric residential treatment facilities (PRTF).

1. Electronic signatures are acceptable.

2. One signature per prescription is required.

3. The pharmacist may sign for a prescription if the beneficiary or his/her representative is not capable of signing. When signing the pharmacist must:

a) Document the circumstances preventing the beneficiary or his/her representative from signing for the prescription, and

b) Sign the prescription signature record with his/her own name and the beneficiary’s name.

4. For shipped or delivered prescriptions, the pharmacy must obtain the signature of the beneficiary or his/her representative and their relationship to the beneficiary.

a) The pharmacy must maintain signatures on-site and in an auditable manner.

b) The Division of Medicaid will not reimburse for medications lost in transit and/or not received by the beneficiary

B. Prescription signature records for received prescriptions must include the prescription serial number, date medication is received and the beneficiary or his/her representative’s signature and their relationship to the beneficiary.

1. Prescription signature records must be retained for a period of five (5) years for audit purposes.

2. Prescription signature records for shipped prescriptions must be retained for a period of five (5) years and must include the delivery confirmation for audit purposes.

3. Prescription signature records must be maintained on-site and in an auditable manner.

C. The beneficiary or provider cannot waive the receipt signature requirement nor does “signature on file” meet this obligation.

Source: Miss. Code Ann. § 43-12-121.

History: Miss Admin. Code, Part 214, Chapter 1, Rule 1.12 A.-E. added 07/01/13 to include 04/01/12 compilation omission

TO SIMPLIFY-

-Mississippi law DOES REQUIRE a signature from a person who is 18 years of age or older in the shipment, mailing or delivery of SCHEDULE ll CONTROLLED SUBSTANCE PRESCRIPTIONS.

-Mississippi law nor the Board of Pharmacy rules DO NOT REQUIRE a signature in the shipment, mailing or delivery of NON-CONTROLLED PRESCRIPTIONS.

-MISSISSIPPI MEDICAID and their MCOs DO have specific requirements as stated above. The pharmacist may sign for a prescription if the beneficiary or his/her representative is not capable of signing, and document the circumstances preventing the beneficiary or his/her representative from signing for the prescription.

This document is being sent electronically to all Mississippi licensed Pharmacists and Pharmacy Benefit Managers.

​​​​​​​​​

CII Drugs- Emergency Declaration | 3/19/2020

RESOLUTION

Whereas, the Mississippi Board of Pharmacy is charged with the protection of the public health as it relates to patient safety, patient health, patient access, and patient services, and

Whereas, Governor Tate Reeves declared a state of emergency on March 14, 2020, concerning the coronavirus and the potential spread of COVID-19; and

Whereas, in the best interest of protecting the public health, the delivery of healthcare services is being facilitated through telemedicine rather than face-to-face examinations; and

Whereas, the Mississippi Board of Pharmacy regulations restrict the prescriptions of Schedule II controlled substances under emergency conditions to a quantity of medication that does not exceed a forty-eight (48) hour supply when the prescription is issued orally; and

Whereas, to facilitate access by the public to drugs that are vital and necessary to maintaining each individual’s health, now therefore;

Be it resolved, that for the duration of the Governor’s declaration of emergency, Article XIX of the Mississippi Board of Pharmacy Regulations shall be suspended with respect to the quantity of Schedule II controlled substances prescribed orally. The Board shall allow a quantity of medication necessary for a thirty (30) day supply for a patient to be dispensed pursuant to an oral prescription for a Schedule II controlled substance during the declaration of emergency.

Be it further resolved, that all other provisions of Article XIX shall remain in effect and all pharmacies permitted by the Mississippi Board of Pharmacy are encouraged to be familiar with the provisions of Article XIX and CFR §1306.11(d).

__________________________

Resolved through an emergency, telephonic meeting of the Mississippi Board of Pharmacy this day, March 18, 2020, at 4:45 o’clock P.M.

​​In response to the Governor’s State of Emergency declaration and potential issues with CII prescriptions, the Board of Pharmacy had an emergency phone in meeting yesterday. Below is the decision that was made.

Please be advised on the following regulations surrounding CII prescriptions-

1. Call in prescriptions for CII drugs are allowed at this time.

2. The normal 48-hour rule has been waived and is now up to a 30-day limit.

3. Pharmacists will need to receive a hard copy of the prescription within 7 days of the called in prescription.

4. This rule is only in effect during the Governor’s Declaration of the State of Emergency.

5. It is recommended that this should only be used in an absolute emergency when a written or electronic prescription may not be obtained. Because of the strict requirement of the 7-day hard copy prescription, there could be major issues with the DEA if this is not followed.

6. Pharmacists are expected to use professional judgment. There is NO requirement to fill any prescription that you determine should not be filled.

***If you have not received the hard copy within the 7-day time period, it is your responsibility to contact the local DEA to report the prescriber or the prescription will be considered an invalid prescription by the DEA. Failure to do so can affect any audit or investigation the DEA performs on you and your facility. ***

Language from the DEA Pharmacist’s Manual:

Emergency Dispensing

An "emergency prescription" in this context, is defined to mean that the immediate administration of the drug is necessary for proper treatment of the intended ultimate user, that no alternative treatment is available (including a drug which is not a schedule II controlled substance), and it is not possible for the prescribing practitioner to provide a written prescription for the drug at that time. In a bona fide emergency, a practitioner may telephone a schedule II prescription to the pharmacist who may then dispense the prescription. The prescribing practitioner must provide a written and signed prescription to the pharmacy within seven days and meet the below requirements:

1. The drug prescribed and dispensed must be limited to the amount needed to treat the patient during the emergency period. Prescribing or dispensing beyond the emergency period must be pursuant to a written prescription order.

2. The prescription order must be immediately reduced to writing by the pharmacist and must contain all information, except for the prescribing practitioner's signature.

3. If the prescribing individual practitioner is not known to the pharmacist, he/she must make a reasonable effort to determine that the oral authorization came from a registered individual practitioner, which may include a call back to the prescribing individual practitioner using his or her telephone number as listed in the telephone directory and/or other good faith efforts to insure his or her identity.

4. Within seven days after authorizing an emergency telephone prescription, the prescribing practitioner must furnish the pharmacist a written, signed prescription for the controlled substance prescribed. The prescription must have written on its face "Authorization for Emergency Dispensing" and the date of the oral order. The written prescription may be delivered to the pharmacist in person or by mail, but if delivered by mail, it must be postmarked within the seven day period. Upon receipt, the dispensing pharmacist must attach this written prescription to the oral emergency prescription which had earlier been reduced to writing by the pharmacist. By regulation, the pharmacist must notify the local DEA Diversion Field Office (Visit www.DEAdiversion.usdoj.gov for current addresses and telephone numbers) if the prescriber fails to provide a written prescription within seven days. Failure of the pharmacist to do so will void the authority conferred on the pharmacy to dispense the controlled substance without a written prescription of a prescribing practitioner.

​​​​​​

COVID-19 Testing Procedure Update | 3/18/2020

Please follow this link​ for updates from the Mississippi Department of Health regarding COVID-19 testing rules. Follow these guidelines supplied to ensure proper, safe testing.

​​​​​​​​​​

The Script: Volume 3 | 1/14/2020


A new issue of The Script, the Mississippi Board of Pharmacy's quarterly newsletter, is out! Click Here to view the latest issue. We encourage you to make this available to your employees and would love to hear your feedback!​

MBP Board Meeting: January 16, 2020 | 1/8/2020

​​

The next meeting of the Mississippi Board of Pharmacy will be Thursday, January 16, at 9:00 a.m. in the MBP Board Room located at 6360 I-55 North, Suite 400 in Jackson. To view upcoming Board Meeting Dates: click here.

Happy New Year! | 12/31/2019

​​

The Mississippi Board of Pharmacy office will be closed tomorrow, January 1, 2020, for New Years Day. We wish you a safe and happy New Year!​

Your Renewal Deadline is TODAY! | 12/31/2019

​​

If you hold a Pharmacist License, Facility Controlled Substance Registration, Medical Gas Wholesaler, Home Health Hospice, Emergency Medication Kit or a Drug Facility Permit with the Mississippi Board of Pharmacy, your renewal deadline is TODAY! Renew Online: http://bit.ly/2HPB5hl

Have You Renewed? 5 Days Left! | 12/27/2019



The clock is ticking with only FIVE DAYS LEFT to renew! Beat the year end rush, renew online today!​​​

Merry Christmas! | 12/23/2019

​​

The Mississippi Board of Pharmacy office will be closed Tuesday, December 24, and Wednesday, December 25, for Christmas. We hope your holiday will be filled with joy and laughter. Merry Christmas!​

MBP Tip Tuesday: Renewal Time! | 12/17/2019

​​

Beat the year end rush, renew online today!

MBP Motivation Monday! | 12/9/2019

​​

Special Meeting of the Mississippi Board of Pharmacy: December 6, 2019 | 12/5/2019

​The Mississippi Board of Pharmacy will hold a special meeting on Friday, December 6, 2019, at the Mississippi Board of Pharmacy office located at 6360 I-55 N. Suite 400, Jackson, MS 39211 beginning at 3:00 p.m. The purpose of the meeting will be to deliberate concerning the job descriptions and salaries of staff. 

Happy Thanksgiving! | 11/27/2019

​​

Our office will be closed Thursday, November 28, and Friday, November 29, for Thanksgiving. We wish you and those dear to you a wonderful and safe Thanksgiving Holiday. May your heart be filled with gratitude and your home be filled with joy!​

MBP Motivation Monday | 11/25/2019



MS Board of Pharmacy Recognizes Agency Partnership | 11/22/2019

​​

Yesterday, the Mississippi Bureau of Narcotics Statewide Pharmaceutical Diversion Unit was recognized by the Mississippi Board of Pharmacy. We are grateful for our partnership with MBN and appreciate the work they do in helping us in our mission to protect Mississippians!​

MBP Board Meeting Agenda: November 21, 2019 | 11/19/2019

​​

The next meeting of the Mississippi Board of Pharmacy will be held on Thursday, November 21, 2019, beginning at 9:00 a.m. in the Board Room of the Mississippi Board of Pharmacy. Our office is located at 6360 I-55 North, Suite 400 in Jackson, Mississippi. To view the agenda for the MBP November Meeting, click here. ​​​​

MBP Motivation Monday | 11/18/2019

​​

MBP Tip Tuesday! | 11/12/2019

​​

Continuing Education Opportunities for Pharmacists | 11/6/2019



Are you a pharmacist looking for Board Approved Continuing Education Opportunities? We have dedicated a page on our website just for you! This page will be updated as new CE opportunities become available. Click Here To View CE Opportunities for Pharmacists

MBP Tip Tuesday! | 11/5/2019

​​

Have a change in Designated Representative for your Drug Facility? Check out our list of required items needed to process this change. To download the Amendment to Permit Form and the Background Check Packet, Click Here.

The Script: Volume 2 | 10/17/2019

​​
A new issue of The Script, the Mississippi Board of Pharmacy's quarterly newsletter, is out! Click Here to view the latest issue. We encourage you to make this available to your employees and would love to hear your feedback!
​​

USP Compounding Update | 10/9/2019



USP has postponed the official dates of the revised USP 795 and 797 due to appeals of certain provisions. The Mississippi Board of Pharmacy will enforce current chapters of USP 795 and 797 until further notice. USP 800 will not be adopted at this time by the Mississippi Board of Pharmacy, but all references to Hazardous Drugs contained in USP 795 and 797 will be enforced.​

Prescriber Notification Update: October 4, 2019 | 10/4/2019

​​

Visit the Prescriber Notification page to view updated information added today. To visit, click here.

MBP FAQ Friday! | 10/4/2019



​​Mississippi Pharmacy Practice Regulations, Article XXXI Compounding Guidelines, requires every pharmacy that performs compounding to obtain a compounding certificate from the Board. This regulation will be strictly enforced beginning January 1, 2020.

​The Compounding Certificate Application is now available on our website. You may download a copy of the application here: https://www.mbp.ms.gov/Documents/2019_Compounding_Application_Fillable.pdf

There is not a fee that accompanies this application. The Compounding Certificate will expire with the corresponding pharmacy permit and must be renewed when the corresponding pharmacy permit is renewed. The Board will also be collecting statistical compounding data for compounded dispensed prescriptions. This data will be collected annually on a form prescribed by the Board. The statistical reporting form is currently in development and once the form has been finalized, it will be sent to all pharmacies and posted on the Board’s website.​​​​​

MBP Regulation Updates | 9/17/2019



The following regulations have been amended and became effective September 14, 2019:
ARTICLE XXV INVENTORY REQUIREMENTS
    • This regulation was amended to allow the annual inventory to be conducted any time during the year as long as it is conducted at the same time each year and to correct an inconsistency between regulations concerning the time allowed to notify the Board of a permanent closing of a facility.
ARTICLE XLIII PRESCRIPTION MONITORING PROGRAM
    • This regulation was amended to require pharmacies to report to the PMP every 24 hours.
ARTICLE XXXI COMPOUNDING GUIDELINES
    • This regulation was amended to allow simple compounding in certain situations, to reduce the burden on compounding for veterinary use and to gather statistical data on compounding.​​
To review all Mississippi Board of Pharmacy RegulationsClick Here.  ​​

Continuing Education Opportunities for Pharmacists | 9/10/2019



New CE Opportunities Available! Click Here To View CE Opportunities for Pharmacists​​

ATTN REQUIRED: Changes to Pharmacy Technician Testing Requirements for PTCB | 8/23/2019

Important changes to the Pharmacy Technician testing requirements for PTCB will take effect January 1, 2020. Details of these changes can be reviewed on the PTCB website: ​https://www.ptcb.org/about-ptcb/certification-program-changes#.XV8D1OhKi70

All questions regarding these updates shoud be directed to PTCB:

Phone: 800.363.8012
Website: www.ptcb.org

Please do not call the Mississippi Board of Pharmacy regarding these changes. For more information, contact PTCB.

MBP Compounding Certificate Application | 8/23/2019

​​Mississippi Pharmacy Practice Regulations, Article XXXI Compounding Guidelines, requires every pharmacy that performs compounding to obtain a compounding certificate from the Board. This regulation will be strictly enforced beginning January 1, 2020.

The Compounding Certificate Application is now available on our website. You may download a copy of the application here: https://www.mbp.ms.gov/Documents/2019_Compounding_Application_Fillable.pdf

There is not a fee that accompanies this application. The Compounding Certificate will expire with the corresponding pharmacy permit and must be renewed when the corresponding pharmacy permit is renewed. The Board will also be collecting statistical compounding data for compounded dispensed prescriptions. This data will be collected annually on a form prescribed by the Board. The statistical reporting form is currently in development and once the form has been finalized, it will be sent to all pharmacies and posted on the Board’s website.​​​

FAQ Friday | 8/16/2019



Out of State Pharmacy School Graduates: Once all four steps have been completed, our office will be able to release you to schedule your test date and location. Please contact us if you have any questions!​​​​

Throwback Thursday: Pharmacy Facts | 8/15/2019



Have You Updated Your Email Address? | 8/9/2019

​​

MBP Tip Tuesday! | 8/6/2019



Did you know you can check the status of your registration/license/permit with the Mississippi Board of Pharmacy through our License Verification Portal? To check your status, click here.

MBP Tip Tuesday! | 7/30/2019

​​

Pharmacy School Graduates: Once we receive your MPJE/NAPLEX scores, you will be able to check you results by clicking here: MPJE/NAPLEX Scores ​​​

Throwback Thursday: Pharmacy Facts | 7/25/2019

​​

MBP Tip Tuesday! | 7/23/2019



Welcome to The Script! | 7/10/2019

​​
The Mississippi Board of Pharmacy is introducing The Script, our new quarterly newsletter. Click Here to view the first issue. We encourage you to make this available to your employees and would love to hear your feedback!

McCoy sworn in as MBP Executive Director | 5/24/2019

Pictured from left: MBP Board Members Clayton Farmer, Jillian Foster, Larry Calvert, Guy Phillips, Todd Barrett, Ronnie Bagwell, 
Pictured from left: MBP Board Members Clayton Farmer, Jillian Foster, Larry Calvert, Guy Phillips, Todd Barrett, Ronnie Bagwell, Justice Jim Kitchens, Executive Director Susan McCoy. Not Pictured: Board Member Ryan Harper. 


At the May 23 meeting of the Mississippi Board of Pharmacy (MBP), Susan McCoy was officially sworn in as Executive Director by Justice James (Jim) Kitchens.

"McCoy brings over three decades of pharmacy experience​ to the Board of Pharmacy,” said Guy Phillips, MBP President. “Her previous experience as a compliance agent and knowledge of state pharmacy regulations will make her successful in her new role as executive director. McCoy began her tenure as Executive Director on April 15, 2019.

Prior to her promotion to Executive Director, McCoy served the MBP as a compliance agent for the last nine and a half years. In addition to her role as a compliance agent, McCoy also brings over 25 years of experience in various pharmacy practices to her new position.

Justice Kitchens was elected in 2016 to a second eight-year term on the Mississippi Supreme Court (Central Distract, Place 3).​

Naloxone Statewide Standing Order | 5/17/2019

Through a standing order issued by the Mississippi State Department of Health, pharmacists are now permitted to dispense by request the narcotic blocker naloxone. A prescription from​ a doctor or other medical practitioner is not required. 

We urge you to read the Joint Press Release issued May 31, 2018: 
To view or download the current Naloxone Statewide Standing Order beginning May 19, 2020:
​​
Please follow these simple steps from Cheri Atwood, Mississippi Board of Pharmacy's Director of Compliance, to dispense: 

  1. ​Maintain proof of completion of the Board-approved training program. 

  2. Maintain a copy of the standing order. 

  3. Reduce the standing order to a prescription (prescriber is the physician that issued the standing order) - fill and file the prescription as a legend drug. 

  4. Provide proper counseling on the use of the medication.  ​​​​
​​​​​​​​
​​​​​​​

MBP Board Meeting Summary Report: March 2019 | 4/1/2019

​​​​​​​​The Mississippi Board of Pharmacy met on March 28, 2019 to conduct business and hold disciplinary hearings. Please click the following link MBP Board Meeting Summary Report: March 2019 to read a synopsis of the items presented or considered by​ the Mississippi Board of Pharmacy during their March meeting. ​​​​​
​​​

Opioid and Benzodiazepine Report: February 2019 | 2/26/2019

​​"Today we are publishing a report update on Opioids and Benzodiazepines prescribed and dispensed in Mississippi through 2018. This report offers all stakeholders accurate information. The Mississippi Board of Pharmacy takes seriously our responsibility to the citizens of Mississippi. Part of that responsibility is not only collecting data through the Prescription Monitoring Program (PMP), but additionally in the detailed analysis of that data. We will continue in our detailed study of this data and share updates when appropriate. In our effort to find ways to battle the Opioid Crisis in Mississippi, it is our hope this information will be used to make appropriate and practical decisions." - - Cheri Atwood, Director of Compliance, Mississippi Board of Pharmacy 

​​

New Research Suggests Opioid Deaths Will Rise Until 2020 | 2/15/2019

​​A new projection of opioid overdose deaths rates suggests that even if there is steady progress in reducing prescription narcotic abuse across the country, the number of fatal overdoses -- which reached 47,600 in 2017 -- will rise sharply in the coming years. To read the full Los Angeles Times article, click here.

Board Member Larry Calvert requested this information be passed along to you as the fight against opioid abuse continues. 

Mississippi Partners with DHA in Opioid Battle | 2/8/2019

​The Mississippi Prescription Monitoring Program has recently partnered with the Defense Health Agency (DHA) in the battle against opioid abuse and addiction. DHA has launched the Military Health System Prescription Monitoring Program (MHSPDMP) giving Mississippi access to controlled substances dispensed at a military facility. Mississippi is one of the nine states currently sharing data with the military’s drug monitoring program. 

Stephanie Mueller, the Director of the MSPMP, shares how this partnership will support our efforts to protect the citizens of Mississippi by enhancing data captured for the protection of opioid use disorder or overdose from prescription overlapping. “With this addition of data sharing, providers will have a broader view of their patient’s care. This is crucial to the state of Mississippi as we continue to fight the opioid crisis in our state and nationally.” ​

To read the full article, click here.

MBP Supports National Wear Red Day! | 2/1/2019

Today we wear RED and stand together with Go Red For Women and the American Heart Association to raise awareness for heart disease and women's heart health! Are you participating in National Wear Red Day? Who are you wearing RED for? 

2019 Pharmacy Technician Renewal | 1/24/2019

​​Online Renewals are now available for Pharmacy Technicians. The April 1, 2019 through March 31, 2020 Pharmacy Technician Renewal is now available for online renewal through our eLicense Portal. Clic​k Here for additional information regarding your renewal and to access the eLicense Portal. If you have not used the online portal before, you will need to register as a new user.

If you were arrested between April 1, 2018 and March 31, 2019, you will need to contact the Mississippi Board of Pharmacy for instruction on submitting a paper renewal application. You will not be able to renew online.

If you have questions or need username/password assistance for the portal, please email: Licensing@mbp.ms.gov


MBP Board Meeting Summary Report: January 2019 | 1/22/2019

​​​​​​The Mississippi Board of Pharmacy met on January 17, 2019 to conduct business and hold disciplinary hearings. Please click the following link MBP Board Meeting Summary Report: January 2019 to read a synopsis of the items presented or considered by​ the Mississippi Board of Pharmacy during their January meeting. ​​​​​
​ ​​

Merry Christmas! | 12/21/2018

We wish you all the joys of the season and happiness throughout the coming year. From all of us at the Mississippi Board of Pharmacy, Merry Christmas and Happy New Year!

The MBP office will be closed on Monday, December 24, and Tuesday, December 25, for Christmas.​



MBP Board Meeting Agenda: November 15, 2018 | 11/15/2018

​​The next meeting of the Mississippi Board of Pharmacy will be held on Thursday, November 15, 2018, beginning at 9:00 a.m. in the Board Room of the Mississippi Board of Pharmacy, 6360 I-55 North, Suite 400, Jackson, Mississippi. To view the agenda for the ​MBP September Meeting, Click Here.
​​​​​​​​​

Opioid Prescribing Guidelines | 11/13/2018

​​The Mississippi Medical Licensure Board (MSMLB) has revised its rules on prescribing opioids in Mississippi. Attached is a quick reference guideline and FAQ page addressing the changes. While the Mississippi Board of Pharmacy does not enforce the MSMLB regulations, we think it is important to provide this information to pharmacists who will be filling the prescriptions and submitting claims for reimbursement.

MSMLB Prescribing Regulation Tools
Quick Reference Guide
FAQs

MBP Board Meeting Agenda September 20, 2018 | 9/17/2018

​​The next meeting of the Mississippi Board of Pharmacy will be held on Thursday, September 20, 2018, beginning at 9:00 a.m. in the Board Room of the Mississippi Board of Pharmacy, 6360 I-55 North, Suite 400, Jackson, Mississippi. To view the agenda for the MBP September Meeting, 

MBP Announces New PMP Website | 8/10/2018

​The Mississippi Board of Pharmacy is excited to announce the new website for the Prescription Monitoring Program. Some of the new features of the site include: 
  • Links to State Agencies and Resources
  • Mississippi Statistics
  • Frequently Asked Questions
  • Fillable Forms to Request Speaker
  • News and Media Links
This new website will be linked to the current PMP tab on the MBP website. The direct URL is: http://pmp.mbp.ms.gov​

MBP Releases Opioid and Benzodiazepine Analytical Report | 8/10/2018

"Today we are publishing a detailed report on Opioids and Benzodiazepines prescribed and dispensed in Mississippi. We have received multiple inquiries on this issue. This report offers all stakeholders accurate information. The Mississippi Board of Pharmacy takes seriously our responsibility to the citizens of Mississippi. Part of that responsibility is not only collecting data through the Prescription Monitoring Program (PMP), but additionally in the detailed analysis of that data. We will continue in our detailed study of this data. In our effort to find ways to battle the Opioid Crisis in Mississippi, it is our hope this information will be used to make appropriate and practical decisions." - -  Steve Parker, Deputy Director, Mississippi Board of Pharmacy

To access a copy of this report, Click Here.  ​​​​​

Online eLicense Renewal Portal Open For Business | 2/14/2018

After weekend maintenance on the online renewal portal, the eLicense Portal is now open once again for online transactions and renewals. Should you have any issues while attempting to renew your license or registration with the Mississippi Board of Pharmacy, please contact Licensing@mbp.ms.gov. Thank you for your patience during this upgrade!

Attention Pharmacists: Has Your PMP Account Been Approved? | 12/13/2017

​If you have recently registered with the PMP, please login and check the status of your account. If your account shows PENDING, send an email to MSPMPASSIST@mbp.ms.gov. The email address you used for your registration will have to be verified by you to complete your PMP registration. 

Attention Pharmacists: Prescription Monitoring Program Registration is Mandatory | 12/7/2017

ATTENTION: Pharmacists NOT registered with the Prescription Monitoring Program (PMP) as of January 1, 2018 WILL have board action taken. Mandatory registration with the PMP went into effect in 2015. This requirement was for EVERY PHARMACIST licensed in Mississippi, regardless of occupation or State of residence.

In addition, if you are NOT registered with the PMP and it is discovered that you checked "yes" (you are registered) on your online renewal, there will be additional fines and/or penalties.

To Register: Click on the link below to open the MS PMP page. Click on create an account and follow the instructions. Make sure you check your email as you will have to verify your email address with the software.

https://mississippi.pmpaware.net

Please email MSPMPASSIST@mbp.ms.gov or call the MSPMP at 601-899-0138 with any questions.


2018 Drug Facility Permit ONLINE RENEWALS Now Available | 12/5/2017

​Online Renewals are now available for all Drug Facility Permit Holders. The January 1, 2018 to December 31, 2018 Drug Facility Renewal is now available for online renewal through our eLicense Portal. Click Here to Access the eLicense Portal. If you have not used the online portal before, you will need to register as a new user.

If you have questions or need username/password assistance for the portal, please email: Licensing@mbp.ms.gov.

2018 Drug Facility Permit Renewal Update | 11/29/2017

The January 1, 2018 to December 31, 2018 Drug Facility Renewal Application is now available through our online eLicense Portal. Click Here to Access the eLicense Portal.  If you have not used the online portal before, you will need to register as a new user. Once you log in you will be able to download a hardcopy renewal form for 2018. We are still working on providing online renewals for all Drug Facility Permit Holders. We will notify everyone via email and our website as soon as online renewals are available. If you have questions or need username/password assistance for the portal, please email: Licensing@mbp.ms.gov. We thank you for your patience!

MBP Board Meeting Agenda - November 16, 2017 | 11/14/2017

​The next meeting of the Mississippi Board of Pharmacy will be held on Thursday, November 14, 2017, beginning at 9:00 a.m. in the Board Room of the Mississippi Board of Pharmacy, 6360 I-55 North, Suite 400, Jackson, Mississippi. To view the agenda for the MBP November Meeting, Click Here.

Effective Immediately: Drug Facility Update | 11/3/2017

​Notification was directed to all Wholesale Facility Permit holders in November 2016 bringing attention to changes occurring with this permit type in Mississippi that were driven by new DSCSA changes. In order for the state of Mississippi to become compliant with these new regulations, all facilities holding a Wholesale Permit with the Mississippi Board of Pharmacy were required to reapply for their license with Mississippi one year ahead of their 2017 expiration date. The new Drug Facility Permit Application was to be received in our office no later than December 31, 2016.

As stated in the November 2016 letter, effective immediately any Wholesale Facility that has not submitted a new Drug Facility Permit Application has been put on inactive status. In order to become compliant with these new regulations you must submit a Drug Facility Permit Application immediately along with a $250 late fee.

To download all documents relating to the Drug Facility Permit Application, Click Here.

2017 Drug Facility Renewal Update: The 2017 Renewal Application for Drug Facility Permit Holders is not yet available. We are working diligently to provide online renewals for all Drug Facility Permits as soon as possible. We will notify everyone via email and our website as soon as these renewals are available. We thank you for your patience!

If you have any questions please email: Licensing@mbp.ms.gov

Emergency Announcement: Tropical Storm Nate | 10/6/2017

​Today Governor Phil Bryant announced an emergency declaration in preparation for the possible landfall of Tropical Storm Nate. As a preemptive measure, the Mississippi Board of Pharmacy is announcing that:

  • As the result of this impending storm and;
  • In the event a pharmacist receives a request for a prescription refill and the pharmacist is unable to obtain refill authorization from the prescriber, the pharmacist may dispense a one-time, 30 day supply, emergency refill of the prescribed NON-CONTROLLED medication, provided that;
  1. The prescription is not for a medicinal drug listed as a Scheduled Controlled Substance;
  2. The medication is essential to the maintenance of life or to the continuation of therapy;
  3. The pharmacist must use his or her professional judgement, the interruption of therapy might reasonably produce undesirable health consequences or may cause physical or mental discomfort;
  4. The pharmacist properly records the dispensing; and
  5. The dispensing pharmacist notifies the prescriber of the emergency dispensing within a reasonable time after the one-time emergency refill dispensing. 

Frank Gammill
Executive Director

Tyson Drug Company and City of Holly Springs Saving Lives | 9/26/2017

​In the 2017 legislative session, the Mississippi Legislature passed House Bill 996 enabling practitioners to prescribe naloxone through standing orders. The law further allows pharmacies to dispense lifesaving naloxone to any person who would potentially be in position to save the life of a person at risk for overdosing.
 
Tyson Drug Company in Holly Springs has been aggressive in taking advantage of this new opportunity to dispense naloxone through a standing order.
 
The pharmacists at Tysons have not only completed a naloxone training program, but have also developed a training class to instruct others how to save a life with naloxone. Seeing the opportunity to make a difference in the community, the Holly Springs Fire Department and Marshall County Sheriff's Deputies partnered with Tysons to receive naloxone training so they could begin carrying naloxone on their response vehicles.
 
In a letter to the Mississippi Board of Pharmacy, the pharmacists at Tysons say the benefits of this partnership are already visible in the community of Holly Springs.
 
Recently, the Holly Springs Fire Department responded to a call for a person who was unconscious and believed to have overdosed on an opioid. Upon arriving at the scene the person was not breathing. The first responder administered naloxone, and within a matter of minutes, the person regained consciousness and began breathing again.
 
The letter concluded saying,
 
"This is just one instance where local first responders are making a difference in their community. This could not have happened without all parties' willingness to work together for the common good of the Holly Springs community. Through the continued success of this partnership, our hope is for other pharmacies in Mississippi to be encouraged to work together with their first responders to provide similar services in their communities."
The Board would like to commend Tysons Drug Company for taking the initiative to work with first responders in their community. Executive Director Frank Gammill said, "Tysons actions are making a real difference. I encourage all pharmacies across the state to follow Tysons lead, and become more involved in the training and distribution of naloxone in their area."

MBP Board Meeting Summary Report: September 2017 | 9/25/2017

The Mississippi Board of Pharmacy met on September 21, 2017 to conduct business and hold disciplinary hearings. ​Please click the following link MBP Board Meeting Summary Report: September 2017 to read a synopsis of the items presented or considered by the Mississippi Board of Pharmacy during their September meeting.

MBP Welcomes Mississippi Secretary of State as Special Guest at the September Meeting | 9/24/2017

e Mississippi Board of Pharmacy was honored to welcome Secretary of State Delbert Hosemann as our guest speaker for the September Board Meeting. We appreciate leaders like Secretary Hosemann who are committed to bringing awareness locally and nationally to the current opioid crisis in Mississippi and doing whatever it takes to ensure the safety of the citizens of Mississippi.

We are grateful for our partnership with Secretary Hosemann and look forward to our continued work together.

URGENT NOTICE: MBP Phone Number Has Been Spoofed | 9/18/2017

URGENT NOTICE

The Mississippi Board of Pharmacy phone number has been spoofed and is being used illegally. The origination of many of these illegal calls is from overseas. If you have received a call from this number and do not have business with us, please regard the call as a fraudulent call and hang up. Spoofing is the process where the originator of a call is able to show, through caller ID, a number and/or name other than the true caller.

Examples of fraudulent calls may include calls relating to Medicare, Back Pain, Medication or Medical Equipment, etc. The Mississippi Board of Pharmacy does not endorse products or contact the public about products or health programs.

Please be assured that the Mississippi Board of Pharmacy is doing everything possible to rectify this situation. All appropriate federal, state and local authorities have been notified of this issue. You may report suspected fraud to the Federal Communications Commission.

We sincerely regret any inconvenience this issue may have caused you.

Governor Bryant's Opioid and Heroin Study Task Force Recommendations | 9/15/2017

​The Governor's Opioid and Heroin Study Task Force has released its recommendations to help Mississippi curb the number of overdoses and death that the opioid epidemic is causing.

The task force presented 41 recommendations in total. The majority of these recommendations are for the health-care-provider community, and for treatment, education and prevention.

To see all of Governor Bryant's Opioid and Heroin Study Task Force Recommendations, Click Here.

NOTICE: Michael Leo Baker, D.O - MS License No. 15475 | 9/14/2017

TO: ALL PHARMACISTS
FROM: Mickey Boyette, Agent, CMBI
Mississippi State Board of Medical Licensure

RE: Michael Leo Baker, D.O.
MS License No. 15475

Please be advised, the above identified Licensee executed a Voluntary Surrender of his Mississippi medical license effective IMMEDIATELY on August 3, 2017. As the result of this action, Licensee is no longer allowed to practice medicine in any form in the State of Mississippi. (This includes the issuance of any prescriptions or, the refilling of any prescriptions previously issued by Licensee).

According to the Board's Administrative Code (which is noted below), all prescriptions previously issued by the Licensee are now null and void based on the following:

Part 2640 Chapter 1: Rule 1.11 Prescription Guidelines - All Medications, Section G specifically states:
  1. Thirty (30) days after the death of the issuing physician.
  2. Thirty (30) days after the issuing physician has moved or otherwise changed the location of his or her practice so as to terminate  the doctor/patient relationship. Termination of the doctor/patient relationship results when a patient is no longer able to seek personal consultation or treatment from the issuing physician.
  3. Insofar as controlled substances are concerned, immediately after the loss of DEA Controlled Substances Privileges by the issuing physician.
  4. Immediately after the revocation, suspension or surrender of the physician's license.

Urgent Notice: Phone In Prescriptions: Dr. Phillip Langsdon - Germantown, TN | 9/12/2017

​If you receive a phone in prescription from Dr. Phillip Langsdon, Germantown, TN, please verify the prescription before filling at 901-755-6465.

If the prescription is not authorized, please contact the Mississippi Bureau of Narcotics at 601-371-3600.

You may contact your MBP Compliance Agent directly or the Mississippi Board of Pharmacy Compliance Division at 601-899-8880 if you have any questions.

Emergency Proclamation - August 30, 2017 | 8/30/2017


The Emergency Procedures passed on August 30, 2017 will also apply to individuals affected by Hurricane Irma.

Pursuant to an Emergency Telephonic Meeting of the Mississippi Board of Pharmacy held on August 30, 2017.

Whereas,   The Mississippi Board of Pharmacy is charged with the protection of the public health as it relates to patient safety, patient health, patient access, and patient services and:

Whereas,   the devastation caused by Hurricane Harvey has displaced numerous citizens of the States of Texas and Louisiana;

Whereas,   as our neighboring citizens face unthinkable destruction, we should offer our help in trying to ease the burden and protect the health of evacuees that may be coming into Mississippi with only the clothes on their backs;

Be it resolved that,   in the event that a pharmacist received a request for a prescription refill and the pharmacist is unable to obtain refill authorization from the prescriber, the pharmacist may dispense a one-time, 30 day supply, emergency refill of the prescribed NON-CONTROLLED medication, provided that;

1. The prescription is not for a medicinal drug listed as a Scheduled Control Substance;
2. The medication is essential to the maintenance of life or to the continuation of therapy;
3. The pharmacist must use his or her professional judgement, the interruption of therapy might reasonably produce undesirable health consequences or may cause physical or mental discomfort;
4. The pharmacist properly records the dispensing; and
5. The dispensing pharmacist notifies the prescriber of the emergency dispensing with a reasonable time after the one-time emergency refill dispensing.

Be it resolved that, this resolution is effective immediately, August 30, 2017, through September 21, 2017.

Two Hour Continuing Education Credit For Pharmacists Attending Town Hall Meetings | 8/16/2017

​The Mississippi Board of Pharmacy has approved allowing two (2) hours of continuing education credit to all pharmacists who attend any of the scheduled Town Hall Meetings. Board staff will be present to validate CE credit.

MBP Board Meeting Agenda - July 20, 2017 | 7/14/2017

The next meeting of the Mississippi Board of Pharmacy will be held on Thursday, July 20, 2017, beginning at 9:00 a.m. in the Board Room of the Mississippi Board of Pharmacy, 6360 I-55 North, Suite 400, Jackson, Mississippi. To view the agenda for the MBP July Meeting, Click Here.

LouFran Gammill | 7/11/2017

​It is with deep sorrow that we inform you of the death of LouFran Gammill. LouFran, wife of Frank Gammill, Mississippi Board of Pharmacy Executive Director, passed away in the early morning hours of July 11, 2017 after a long battle with Alzheimer's. Each of us not only grieves the passing of LouFran but also for the loss this family suffers.

Services to honor Mrs. Gammill's life will be:
Wednesday, July 12, 2017
Hazlehurst United Methodist Church
127 Caldwell Drive : Hazlehurst, MS 39083

The Memorial service will be at 2:00 p.m. with a public visitation at the church beginning at 12:00 p.m. The Graveside Committal Service will be at the Union Church Cemetery in Union Church, MS.

Please keep Frank and his family in your prayers. We are attempting to notify the entire pharmacy family. To assist us in this effort, please forward this information as you deem appropriate.

MISSISSIPPI BOARD OFFICES CLOSURE: Out of respect for LouFran, Frank, and the entire Gammill Family, The Board of Pharmacy Office will be closed on Wednesday, July 12, 2017. We will reopen for regular business hours on Thursday, July 13. This will also allow the staff of the Board to attend services.  Thank you.

Mark Your Calendars! Dates Scheduled for Opioid Addiction Town Hall Meetings Happening Summer 2017 | 6/22/2017

​The Mississippi Board of Pharmacy, in partnership with the Department of Mental Health, the Mississippi Bureau of Narcotics, and the Jackson Division of the FBI, are hosting multiple Opioid Town Hall Rallies throughout Mississippi to bring awareness to communities across our state about opioid abuse and what you can do to help reduce the death and destruction caused by opioid addiction.

The next Opioid Town Hall Rally will be in Hattiesburg on June 27. Additional rallies have been scheduled for the following dates: July 18 in Tupelo - August 1 in Southaven and August 15 in Columbus. For more information about upcoming Opioid Town Hall Rallies, Click Here.

Department of Mental Health Hosts Second Town Hall Meeting To Discuss Opioid Addiction | 6/8/2017

​A town hall meeting will be held on June 13 in Diamondhead, MS to address the growing impact of opioids in communities across the state. This meeting is hosted in partnership with the Department of Mental Health, the Bureau of Narcotics, the Board of Pharmacy, and the Jackson Division of the FBI. The meeting will take place at Diamondhead City Hall in the Council Chambers located at 5000 Diamondhead Circle.

For more information, Click Here.

This meeting is the second in a series of town halls that will be held throughout the state in the coming months. The town hall meetings will also share information from Governor Bryant's Opioid and Heroin Study Task Force that is expected to release recommendations later this summer.

Department of Mental Health Hosts Town Hall Meeting To Discuss Opioid Addiction | 5/12/2017

​A town hall meeting in Brandon this month will address the growing impact of opioids in communities across the state. The meeting is hosted in a partnership with the Department of Mental Health, the Bureau of Narcotics, the Board of Pharmacy, and the Jackson Division of the FBI. The meeting will be held at the Brandon Civic Center on May 23 at 6:30 p.m. For more information, Click Here.

​This meeting is just one in a series of town halls that will be held throughout the state in the coming months. The town halls will also share information from Governor Bryant's Opioid and Heroin Study Task Force that is expected to release recommendations later this summer. 

27th Annual MARP Seminar: Understanding Roadblocks To Recovery | 5/11/2017

​The 27th Annual MARP Seminar presented by The Mississippi Association of Recovering Pharmacists (MARP) will be held August 19-20, 2017 at the Trotter Convention Center in Columbus, MS. For more information about this event, Click Here.

As a reminder, each newly licensed pharmacist, effective May 1, 2013, in the State of Mississippi is required to attend a MARP sponsored seminar consisting of a minimum of 6 continuing education contact hours once during his/her first 5 years of licensure. This requirement will only apply to Mississippi licensed Pharmacists who actively engage in the practice of pharmacy in the State of Mississippi. For more information on this requirement, Click Here.

Continuing Education Requirements |

MBP Naloxone Training |

|

|

 ​​
​​​​​​
​​​​​​​​​​​​​​​​​ ​​​​​​​​​​​​​​​​​​​​​​​​​​​​​​